These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20101062)

  • 1. Severe adverse skin reactions to nonsteroidal antiinflammatory drugs: A review of the literature.
    Ward KE; Archambault R; Mersfelder TL
    Am J Health Syst Pharm; 2010 Feb; 67(3):206-13. PubMed ID: 20101062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
    La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
    Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serious skin reactions and selective COX-2 inhibitors: a case series from prescription-event monitoring in England.
    Layton D; Marshall V; Boshier A; Friedmann P; Shakir SA
    Drug Saf; 2006; 29(8):687-96. PubMed ID: 16872242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with nonsteroidal antiinflammatory drugs: a multinational perspective.
    Mockenhaupt M; Kelly JP; Kaufman D; Stern RS;
    J Rheumatol; 2003 Oct; 30(10):2234-40. PubMed ID: 14528522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxic epidermal necrolysis and Stevens-Johnson syndrome. An epidemiologic study from West Germany.
    Schöpf E; Stühmer A; Rzany B; Victor N; Zentgraf R; Kapp JF
    Arch Dermatol; 1991 Jun; 127(6):839-42. PubMed ID: 2036029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profile and pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a general hospital in Singapore: treatment outcomes.
    Tan SK; Tay YK
    Acta Derm Venereol; 2012 Jan; 92(1):62-6. PubMed ID: 21710108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous adverse event reports of Stevens-Johnson syndrome/toxic epidermal necrolysis: detecting associations with medications.
    Papay J; Yuen N; Powell G; Mockenhaupt M; Bogenrieder T
    Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):289-96. PubMed ID: 22139991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stevens Johnson syndrome, toxic epidermal necrolysis and SJS-TEN overlap: a retrospective study of causative drugs and clinical outcome.
    Sharma VK; Sethuraman G; Minz A
    Indian J Dermatol Venereol Leprol; 2008; 74(3):238-40. PubMed ID: 18583791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Harr T; French LE
    Chem Immunol Allergy; 2012; 97():149-66. PubMed ID: 22613860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stevens-Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs: An analysis of the US Food and Drug Administration Adverse Event Reporting System.
    Borrelli EP; Lee EY; Descoteaux AM; Kogut SJ; Caffrey AR
    Epilepsia; 2018 Dec; 59(12):2318-2324. PubMed ID: 30395352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in vietnamese spontaneous adverse drug reaction database: A subgroup approach to disproportionality analysis.
    Nguyen KD; Tran TN; Nguyen MT; Nguyen HA; Nguyen HA; Vu DH; Nguyen VD; Bagheri H
    J Clin Pharm Ther; 2019 Feb; 44(1):69-77. PubMed ID: 30129156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: a multicentric retrospective study.
    Barvaliya M; Sanmukhani J; Patel T; Paliwal N; Shah H; Tripathi C
    J Postgrad Med; 2011; 57(2):115-9. PubMed ID: 21654132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children: 20 years study in a tertiary care hospital.
    Techasatian L; Panombualert S; Uppala R; Jetsrisuparb C
    World J Pediatr; 2017 Jun; 13(3):255-260. PubMed ID: 27650525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical aspects of skin reactions to NSAIDs.
    Roujeau JC
    Scand J Rheumatol Suppl; 1987; 65():131-4. PubMed ID: 2961055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of cutaneous adverse drug reactions.
    Mockenhaupt M
    Chem Immunol Allergy; 2012; 97():1-17. PubMed ID: 22613850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of toxic epidermal necrolysis and Stevens-Johnson syndrome associated with benzodiazepines: a population-based cohort study.
    Martín-Merino E; de Abajo FJ; Gil M
    Eur J Clin Pharmacol; 2015 Jun; 71(6):759-766. PubMed ID: 25939709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.
    Roujeau JC; Kelly JP; Naldi L; Rzany B; Stern RS; Anderson T; Auquier A; Bastuji-Garin S; Correia O; Locati F
    N Engl J Med; 1995 Dec; 333(24):1600-7. PubMed ID: 7477195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lamotrigine-induced severe cutaneous adverse reactions.
    Schlienger RG; Shapiro LE; Shear NH
    Epilepsia; 1998; 39 Suppl 7():S22-6. PubMed ID: 9798758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of toxic epidermal necrolysis and Stevens-Johnson Syndrome in an HIV cohort: an observational, retrospective case series study.
    Mittmann N; Knowles SR; Koo M; Shear NH; Rachlis A; Rourke SB
    Am J Clin Dermatol; 2012 Feb; 13(1):49-54. PubMed ID: 22145749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan from 2000 to 2006.
    Yamane Y; Aihara M; Ikezawa Z
    Allergol Int; 2007 Dec; 56(4):419-25. PubMed ID: 17713361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.